Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 05 08 2023
revised: 02 05 2024
accepted: 02 07 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: ppublish

Résumé

Laparoscopic liver surgery is increasingly used for more challenging procedures. The aim of this study was to assess the feasibility and oncological safety of laparoscopic right hepatectomy for colorectal liver metastases after portal vein embolization. This was an international retrospective multicentre study of patients with colorectal liver metastases who underwent open or laparoscopic right and extended right hepatectomy after portal vein embolization between 2004 and 2020. The perioperative and oncological outcomes for patients who underwent laparoscopic and open approaches were compared using propensity score matching. Of 338 patients, 84 patients underwent a laparoscopic procedure and 254 patients underwent an open procedure. Patients in the laparoscopic group less often underwent extended right hepatectomy (18% versus 34.6% (P = 0.004)), procedures in the setting of a two-stage hepatectomy (42% versus 65% (P < 0.001)), and major concurrent procedures (4% versus 16.1% (P = 0.003)). After propensity score matching, 78 patients remained in each group. The laparoscopic approach was associated with longer operating and Pringle times (330 versus 258.5 min (P < 0.001) and 65 versus 30 min (P = 0.001) respectively) and a shorter length of stay (7 versus 8 days (P = 0.011)). The R0 resection rate was not different (71% for the laparoscopic approach versus 60% for the open approach (P = 0.230)). The median disease-free survival was 12 (95% c.i. 10 to 20) months for the laparoscopic approach versus 20 (95% c.i. 13 to 31) months for the open approach (P = 0.145). The median overall survival was 28 (95% c.i. 22 to 48) months for the laparoscopic approach versus 42 (95% c.i. 35 to 52) months for the open approach (P = 0.614). The advantages of a laparoscopic over an open approach for (extended) right hepatectomy for colorectal liver metastases after portal vein embolization are limited.

Sections du résumé

BACKGROUND BACKGROUND
Laparoscopic liver surgery is increasingly used for more challenging procedures. The aim of this study was to assess the feasibility and oncological safety of laparoscopic right hepatectomy for colorectal liver metastases after portal vein embolization.
METHODS METHODS
This was an international retrospective multicentre study of patients with colorectal liver metastases who underwent open or laparoscopic right and extended right hepatectomy after portal vein embolization between 2004 and 2020. The perioperative and oncological outcomes for patients who underwent laparoscopic and open approaches were compared using propensity score matching.
RESULTS RESULTS
Of 338 patients, 84 patients underwent a laparoscopic procedure and 254 patients underwent an open procedure. Patients in the laparoscopic group less often underwent extended right hepatectomy (18% versus 34.6% (P = 0.004)), procedures in the setting of a two-stage hepatectomy (42% versus 65% (P < 0.001)), and major concurrent procedures (4% versus 16.1% (P = 0.003)). After propensity score matching, 78 patients remained in each group. The laparoscopic approach was associated with longer operating and Pringle times (330 versus 258.5 min (P < 0.001) and 65 versus 30 min (P = 0.001) respectively) and a shorter length of stay (7 versus 8 days (P = 0.011)). The R0 resection rate was not different (71% for the laparoscopic approach versus 60% for the open approach (P = 0.230)). The median disease-free survival was 12 (95% c.i. 10 to 20) months for the laparoscopic approach versus 20 (95% c.i. 13 to 31) months for the open approach (P = 0.145). The median overall survival was 28 (95% c.i. 22 to 48) months for the laparoscopic approach versus 42 (95% c.i. 35 to 52) months for the open approach (P = 0.614).
CONCLUSION CONCLUSIONS
The advantages of a laparoscopic over an open approach for (extended) right hepatectomy for colorectal liver metastases after portal vein embolization are limited.

Identifiants

pubmed: 39136268
pii: 7732310
doi: 10.1093/bjs/znae181
pii:
doi:

Types de publication

Journal Article Multicenter Study Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.

Auteurs

Emre Bozkurt (E)

Department of Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Department of Surgery, Koç University School of Medicine, Istanbul, Turkey.

Jasper P Sijberden (JP)

Department of Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

Serena Langella (S)

Department of General and Oncological Surgery, Umberto I Mauriziano Hospital, Turin, Italy.

Federica Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Francesc Collado-Roura (F)

Servei de Cirurgia General i Digestiva, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.

Victoria Morrison-Jones (V)

Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Burak Görgec (B)

Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

Gabriel Zozaya (G)

Department of Surgery, HPB and Liver Transplantation Unit, University Clinic, Universidad de Navarra, Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Jacopo Lanari (J)

Department of Surgical, Oncological and Gastroenterological Sciences, General Surgery 2, Hepato-pancreato-biliary Surgery and Liver Transplantation, Padua University Hospital, Padua, Italy.

Davit Aghayan (D)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital and Institute of Medicine, University of Oslo, Oslo, Norway.

Celine De Meyere (C)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

David Fuks (D)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.

Giuseppe Zimmiti (G)

Department of Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

Benedetto Ielpo (B)

Hepatobiliary and Pancreatic Surgery Unit, Hospital del Mar, Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

Mikhail Efanov (M)

Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Research Centre, Moscow, Russia.

Robert P Sutcliffe (RP)

Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.

Nadia Russolillo (N)

Department of General and Oncological Surgery, Umberto I Mauriziano Hospital, Turin, Italy.

Miquel Gomez-Artacho (M)

Servei de Cirurgia General i Digestiva, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.

Francesca Ratti (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Bjørn Edwin (B)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital and Institute of Medicine, University of Oslo, Oslo, Norway.

Umberto Cillo (U)

Department of Surgical, Oncological and Gastroenterological Sciences, General Surgery 2, Hepato-pancreato-biliary Surgery and Liver Transplantation, Padua University Hospital, Padua, Italy.

Fernando Rotellar (F)

Department of Surgery, HPB and Liver Transplantation Unit, University Clinic, Universidad de Navarra, Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Marc G Besselink (MG)

Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Amsterdam, The Netherlands.

John N Primrose (JN)

Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Santi Lopez-Ben (S)

Servei de Cirurgia General i Digestiva, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.

Luca A Aldrighetti (LA)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Umberto I Mauriziano Hospital, Turin, Italy.

Mohammad Abu Hilal (M)

Department of Surgery, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH